Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis.
Identifieur interne : 002D24 ( PubMed/Checkpoint ); précédent : 002D23; suivant : 002D25Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis.
Auteurs : Nicholas Bellamy [Australie] ; Marc Hochberg [États-Unis] ; Florence Tubach [France] ; Emilio Martin-Mola [Espagne] ; Hassane Awada [Liban] ; Claire Bombardier [Canada] ; Najia Hajjaj-Hassouni [Maroc] ; Isabelle Logeart [France] ; Marco Matucci-Cerinic [Italie] ; Mart Van De Laar [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France]Source :
- Arthritis care & research [ 2151-4658 ] ; 2015.
Descripteurs français
- KwdFr :
- Anti-inflammatoires non stéroïdiens (usage thérapeutique), Arthrose (), Arthrose (diagnostic), Arthrose (épidémiologie), Australie (épidémiologie), Europe (épidémiologie), Femelle, Humains, Internationalité, Liban (épidémiologie), Maroc (épidémiologie), Mesure de la douleur (), Mesure de la douleur (normes), Mâle, Résultat thérapeutique, Satisfaction du patient, Études longitudinales, Études prospectives.
- MESH :
- diagnostic : Arthrose.
- normes : Mesure de la douleur.
- usage thérapeutique : Anti-inflammatoires non stéroïdiens.
- épidémiologie : Arthrose, Australie, Europe, Liban, Maroc.
- Arthrose, Femelle, Humains, Internationalité, Mesure de la douleur, Mâle, Résultat thérapeutique, Satisfaction du patient, Études longitudinales, Études prospectives.
- Wicri :
English descriptors
- KwdEn :
- Anti-Inflammatory Agents, Non-Steroidal (therapeutic use), Australia (epidemiology), Europe (epidemiology), Female, Humans, Internationality, Lebanon (epidemiology), Longitudinal Studies, Male, Morocco (epidemiology), Osteoarthritis (diagnosis), Osteoarthritis (epidemiology), Osteoarthritis (therapy), Pain Measurement (methods), Pain Measurement (standards), Patient Satisfaction, Prospective Studies, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Anti-Inflammatory Agents, Non-Steroidal.
- geographic , epidemiology : Australia, Europe, Lebanon, Morocco.
- diagnosis : Osteoarthritis.
- epidemiology : Osteoarthritis.
- methods : Pain Measurement.
- standards : Pain Measurement.
- therapy : Osteoarthritis.
- Female, Humans, Internationality, Longitudinal Studies, Male, Patient Satisfaction, Prospective Studies, Treatment Outcome.
Abstract
The ability to interpret scores from patient-reported outcome measures at the individual patient level depends on the availability of valid, clinically meaningful benchmarks of response and state attainment. The goal was to develop multinational estimates for minimal clinically important improvement (MCII) and patient acceptable symptomatic state (PASS).
DOI: 10.1002/acr.22538
PubMed: 25581339
Affiliations:
- Australie, Canada, Espagne, France, Italie, Liban, Maroc, Pays-Bas, États-Unis
- Communauté de Madrid, Hollande-Méridionale, Maryland, Ontario, Île-de-France
- Baltimore, Leyde, Madrid, Paris, Toronto
- Université de Toronto
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25581339Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis.</title><author><name sortKey="Bellamy, Nicholas" sort="Bellamy, Nicholas" uniqKey="Bellamy N" first="Nicholas" last="Bellamy">Nicholas Bellamy</name><affiliation wicri:level="1"><nlm:affiliation>University of Queensland School of Medicine, Brisbane, Queensland, Australia, and Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Queensland School of Medicine, Brisbane, Queensland, Australia, and Royal Brisbane and Women's Hospital, Herston, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Hochberg, Marc" sort="Hochberg, Marc" uniqKey="Hochberg M" first="Marc" last="Hochberg">Marc Hochberg</name><affiliation wicri:level="3"><nlm:affiliation>University of Maryland School of Medicine, Baltimore.</nlm:affiliation><country>États-Unis</country><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region></placeName><wicri:orgArea>University of Maryland School of Medicine</wicri:orgArea></affiliation></author><author><name sortKey="Tubach, Florence" sort="Tubach, Florence" uniqKey="Tubach F" first="Florence" last="Tubach">Florence Tubach</name><affiliation wicri:level="3"><nlm:affiliation>Université Paris Diderot, Sorbonne Paris Cité, INSERM, UMR-S 1123, INSERM, CIC 1425-EC, UMR-S 1123, and AP-HP Hôpital Bichat, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Paris Diderot, Sorbonne Paris Cité, INSERM, UMR-S 1123, INSERM, CIC 1425-EC, UMR-S 1123, and AP-HP Hôpital Bichat, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Martin Mola, Emilio" sort="Martin Mola, Emilio" uniqKey="Martin Mola E" first="Emilio" last="Martin-Mola">Emilio Martin-Mola</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Universitario La Paz and Universidad Autónoma Madrid, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario La Paz and Universidad Autónoma Madrid, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Awada, Hassane" sort="Awada, Hassane" uniqKey="Awada H" first="Hassane" last="Awada">Hassane Awada</name><affiliation wicri:level="1"><nlm:affiliation>Saint Joseph University Hôtel-Dieu de France, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Saint Joseph University Hôtel-Dieu de France, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Bombardier, Claire" sort="Bombardier, Claire" uniqKey="Bombardier C" first="Claire" last="Bombardier">Claire Bombardier</name><affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Toronto General Research Institute, Institute for Work and Health, and Mount Sinai Hospital, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Toronto, Toronto General Research Institute, Institute for Work and Health, and Mount Sinai Hospital, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Hajjaj Hassouni, Najia" sort="Hajjaj Hassouni, Najia" uniqKey="Hajjaj Hassouni N" first="Najia" last="Hajjaj-Hassouni">Najia Hajjaj-Hassouni</name><affiliation wicri:level="1"><nlm:affiliation>Mohammed Vth Souissi University, CNRST, and Laboratory of Information and Research on Bone Diseases (LIRPOS-URAC 30), Rabat, Morocco, and El Ayachi Hospital and University Hospital, Salé, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Mohammed Vth Souissi University, CNRST, and Laboratory of Information and Research on Bone Diseases (LIRPOS-URAC 30), Rabat, Morocco, and El Ayachi Hospital and University Hospital, Salé</wicri:regionArea><wicri:noRegion>Salé</wicri:noRegion></affiliation></author><author><name sortKey="Logeart, Isabelle" sort="Logeart, Isabelle" uniqKey="Logeart I" first="Isabelle" last="Logeart">Isabelle Logeart</name><affiliation wicri:level="3"><nlm:affiliation>Pfizer, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pfizer, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Matucci Cerinic, Marco" sort="Matucci Cerinic, Marco" uniqKey="Matucci Cerinic M" first="Marco" last="Matucci-Cerinic">Marco Matucci-Cerinic</name><affiliation wicri:level="1"><nlm:affiliation>Denothe Centre, University of Florence, Florence, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Denothe Centre, University of Florence, Florence</wicri:regionArea><wicri:noRegion>Florence</wicri:noRegion></affiliation></author><author><name sortKey="Van De Laar, Mart" sort="Van De Laar, Mart" uniqKey="Van De Laar M" first="Mart" last="Van De Laar">Mart Van De Laar</name><affiliation wicri:level="1"><nlm:affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University Twente, Enschede, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Arthritis Center Twente, Medisch Spectrum Twente, and University Twente, Enschede</wicri:regionArea><wicri:noRegion>Enschede</wicri:noRegion></affiliation></author><author><name sortKey="Van Der Heijde, Desiree" sort="Van Der Heijde, Desiree" uniqKey="Van Der Heijde D" first="Désirée" last="Van Der Heijde">Désirée Van Der Heijde</name><affiliation wicri:level="3"><nlm:affiliation>Leiden University Medical Center, Leiden, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Leiden University Medical Center, Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Dougados, Maxime" sort="Dougados, Maxime" uniqKey="Dougados M" first="Maxime" last="Dougados">Maxime Dougados</name><affiliation wicri:level="3"><nlm:affiliation>Paris Descartes University, Cochin Hospital, AP-HP, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Paris Descartes University, Cochin Hospital, AP-HP, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25581339</idno><idno type="pmid">25581339</idno><idno type="doi">10.1002/acr.22538</idno><idno type="wicri:Area/PubMed/Corpus">002B78</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B78</idno><idno type="wicri:Area/PubMed/Curation">002B06</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B06</idno><idno type="wicri:Area/PubMed/Checkpoint">002B06</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002B06</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis.</title><author><name sortKey="Bellamy, Nicholas" sort="Bellamy, Nicholas" uniqKey="Bellamy N" first="Nicholas" last="Bellamy">Nicholas Bellamy</name><affiliation wicri:level="1"><nlm:affiliation>University of Queensland School of Medicine, Brisbane, Queensland, Australia, and Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Queensland School of Medicine, Brisbane, Queensland, Australia, and Royal Brisbane and Women's Hospital, Herston, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Hochberg, Marc" sort="Hochberg, Marc" uniqKey="Hochberg M" first="Marc" last="Hochberg">Marc Hochberg</name><affiliation wicri:level="3"><nlm:affiliation>University of Maryland School of Medicine, Baltimore.</nlm:affiliation><country>États-Unis</country><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region></placeName><wicri:orgArea>University of Maryland School of Medicine</wicri:orgArea></affiliation></author><author><name sortKey="Tubach, Florence" sort="Tubach, Florence" uniqKey="Tubach F" first="Florence" last="Tubach">Florence Tubach</name><affiliation wicri:level="3"><nlm:affiliation>Université Paris Diderot, Sorbonne Paris Cité, INSERM, UMR-S 1123, INSERM, CIC 1425-EC, UMR-S 1123, and AP-HP Hôpital Bichat, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Paris Diderot, Sorbonne Paris Cité, INSERM, UMR-S 1123, INSERM, CIC 1425-EC, UMR-S 1123, and AP-HP Hôpital Bichat, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Martin Mola, Emilio" sort="Martin Mola, Emilio" uniqKey="Martin Mola E" first="Emilio" last="Martin-Mola">Emilio Martin-Mola</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Universitario La Paz and Universidad Autónoma Madrid, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario La Paz and Universidad Autónoma Madrid, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Awada, Hassane" sort="Awada, Hassane" uniqKey="Awada H" first="Hassane" last="Awada">Hassane Awada</name><affiliation wicri:level="1"><nlm:affiliation>Saint Joseph University Hôtel-Dieu de France, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Saint Joseph University Hôtel-Dieu de France, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Bombardier, Claire" sort="Bombardier, Claire" uniqKey="Bombardier C" first="Claire" last="Bombardier">Claire Bombardier</name><affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Toronto General Research Institute, Institute for Work and Health, and Mount Sinai Hospital, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Toronto, Toronto General Research Institute, Institute for Work and Health, and Mount Sinai Hospital, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Hajjaj Hassouni, Najia" sort="Hajjaj Hassouni, Najia" uniqKey="Hajjaj Hassouni N" first="Najia" last="Hajjaj-Hassouni">Najia Hajjaj-Hassouni</name><affiliation wicri:level="1"><nlm:affiliation>Mohammed Vth Souissi University, CNRST, and Laboratory of Information and Research on Bone Diseases (LIRPOS-URAC 30), Rabat, Morocco, and El Ayachi Hospital and University Hospital, Salé, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Mohammed Vth Souissi University, CNRST, and Laboratory of Information and Research on Bone Diseases (LIRPOS-URAC 30), Rabat, Morocco, and El Ayachi Hospital and University Hospital, Salé</wicri:regionArea><wicri:noRegion>Salé</wicri:noRegion></affiliation></author><author><name sortKey="Logeart, Isabelle" sort="Logeart, Isabelle" uniqKey="Logeart I" first="Isabelle" last="Logeart">Isabelle Logeart</name><affiliation wicri:level="3"><nlm:affiliation>Pfizer, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pfizer, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Matucci Cerinic, Marco" sort="Matucci Cerinic, Marco" uniqKey="Matucci Cerinic M" first="Marco" last="Matucci-Cerinic">Marco Matucci-Cerinic</name><affiliation wicri:level="1"><nlm:affiliation>Denothe Centre, University of Florence, Florence, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Denothe Centre, University of Florence, Florence</wicri:regionArea><wicri:noRegion>Florence</wicri:noRegion></affiliation></author><author><name sortKey="Van De Laar, Mart" sort="Van De Laar, Mart" uniqKey="Van De Laar M" first="Mart" last="Van De Laar">Mart Van De Laar</name><affiliation wicri:level="1"><nlm:affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University Twente, Enschede, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Arthritis Center Twente, Medisch Spectrum Twente, and University Twente, Enschede</wicri:regionArea><wicri:noRegion>Enschede</wicri:noRegion></affiliation></author><author><name sortKey="Van Der Heijde, Desiree" sort="Van Der Heijde, Desiree" uniqKey="Van Der Heijde D" first="Désirée" last="Van Der Heijde">Désirée Van Der Heijde</name><affiliation wicri:level="3"><nlm:affiliation>Leiden University Medical Center, Leiden, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Leiden University Medical Center, Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Dougados, Maxime" sort="Dougados, Maxime" uniqKey="Dougados M" first="Maxime" last="Dougados">Maxime Dougados</name><affiliation wicri:level="3"><nlm:affiliation>Paris Descartes University, Cochin Hospital, AP-HP, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Paris Descartes University, Cochin Hospital, AP-HP, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Arthritis care & research</title><idno type="eISSN">2151-4658</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)</term><term>Australia (epidemiology)</term><term>Europe (epidemiology)</term><term>Female</term><term>Humans</term><term>Internationality</term><term>Lebanon (epidemiology)</term><term>Longitudinal Studies</term><term>Male</term><term>Morocco (epidemiology)</term><term>Osteoarthritis (diagnosis)</term><term>Osteoarthritis (epidemiology)</term><term>Osteoarthritis (therapy)</term><term>Pain Measurement (methods)</term><term>Pain Measurement (standards)</term><term>Patient Satisfaction</term><term>Prospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anti-inflammatoires non stéroïdiens (usage thérapeutique)</term><term>Arthrose ()</term><term>Arthrose (diagnostic)</term><term>Arthrose (épidémiologie)</term><term>Australie (épidémiologie)</term><term>Europe (épidémiologie)</term><term>Femelle</term><term>Humains</term><term>Internationalité</term><term>Liban (épidémiologie)</term><term>Maroc (épidémiologie)</term><term>Mesure de la douleur ()</term><term>Mesure de la douleur (normes)</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Satisfaction du patient</term><term>Études longitudinales</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents, Non-Steroidal</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Australia</term><term>Europe</term><term>Lebanon</term><term>Morocco</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Osteoarthritis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Arthrose</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Osteoarthritis</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Pain Measurement</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Mesure de la douleur</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Pain Measurement</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Osteoarthritis</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires non stéroïdiens</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Arthrose</term><term>Australie</term><term>Europe</term><term>Liban</term><term>Maroc</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Internationality</term><term>Longitudinal Studies</term><term>Male</term><term>Patient Satisfaction</term><term>Prospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Arthrose</term><term>Femelle</term><term>Humains</term><term>Internationalité</term><term>Mesure de la douleur</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Satisfaction du patient</term><term>Études longitudinales</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Australie</term><term>Liban</term><term>Maroc</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The ability to interpret scores from patient-reported outcome measures at the individual patient level depends on the availability of valid, clinically meaningful benchmarks of response and state attainment. The goal was to develop multinational estimates for minimal clinically important improvement (MCII) and patient acceptable symptomatic state (PASS).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25581339</PMID><DateCreated><Year>2015</Year><Month>06</Month><Day>26</Day></DateCreated><DateCompleted><Year>2015</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2151-4658</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Arthritis care & research</Title><ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation></Journal><ArticleTitle>Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis.</ArticleTitle><Pagination><MedlinePgn>972-80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.22538</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The ability to interpret scores from patient-reported outcome measures at the individual patient level depends on the availability of valid, clinically meaningful benchmarks of response and state attainment. The goal was to develop multinational estimates for minimal clinically important improvement (MCII) and patient acceptable symptomatic state (PASS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multinational sample of patients with osteoarthritis (OA) was evaluated before and 4 weeks after treatment with nonsteroidal antiinflammatory drugs. Patients completed either the Western Ontario and McMaster Osteoarthritis Index (WOMAC) numerical rating scale 3.1 (hip and knee OA) or the Australian/Canadian Index (AUSCAN) numerical rating scale 3.1 (hand OA) before and after treatment. Patients rated the clinical importance of their response to treatment and their satisfaction with the health state achieved, from which multinational MCII and PASS estimates were calculated for both the WOMAC and AUSCAN indices.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 609 patients from 7 countries participated in the study. MCII and PASS estimates varied slightly by instrument and subscale. Absolute (percentage) change for MCII ranged 6-9 (10% to 17%) for WOMAC and 4-9 (8% to 15%) for AUSCAN. PASS estimates ranged 39-48 for WOMAC and 38-45 for AUSCAN. Some between-country variation was observed in MCII and PASS.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Preliminary multinational estimates for MCII and PASS have been developed for several countries. Further research is required to evaluate the robustness, temporal consistency, and age- and sex-dependency of the preliminary estimates as well as their generalizability to other countries, languages, cultures, regions, and other condition-specific outcome measures.</AbstractText><CopyrightInformation>© 2015, American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellamy</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Queensland School of Medicine, Brisbane, Queensland, Australia, and Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hochberg</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Maryland School of Medicine, Baltimore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tubach</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Université Paris Diderot, Sorbonne Paris Cité, INSERM, UMR-S 1123, INSERM, CIC 1425-EC, UMR-S 1123, and AP-HP Hôpital Bichat, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin-Mola</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz and Universidad Autónoma Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awada</LastName><ForeName>Hassane</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Saint Joseph University Hôtel-Dieu de France, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bombardier</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Toronto, Toronto General Research Institute, Institute for Work and Health, and Mount Sinai Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajjaj-Hassouni</LastName><ForeName>Najia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Mohammed Vth Souissi University, CNRST, and Laboratory of Information and Research on Bone Diseases (LIRPOS-URAC 30), Rabat, Morocco, and El Ayachi Hospital and University Hospital, Salé, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logeart</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pfizer, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matucci-Cerinic</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Denothe Centre, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Laar</LastName><ForeName>Mart</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Heijde</LastName><ForeName>Désirée</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dougados</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Paris Descartes University, Cochin Hospital, AP-HP, INSERM (U1153), PRES Sorbonne Paris-Cité, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA><NlmUniqueID>101518086</NlmUniqueID><ISSNLinking>2151-464X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038622" MajorTopicYN="Y">Internationality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007861" MajorTopicYN="N" Type="Geographic">Lebanon</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009018" MajorTopicYN="N" Type="Geographic">Morocco</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010003" MajorTopicYN="N">Osteoarthritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="Y">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>07</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25581339</ArticleId><ArticleId IdType="doi">10.1002/acr.22538</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Canada</li><li>Espagne</li><li>France</li><li>Italie</li><li>Liban</li><li>Maroc</li><li>Pays-Bas</li><li>États-Unis</li></country><region><li>Communauté de Madrid</li><li>Hollande-Méridionale</li><li>Maryland</li><li>Ontario</li><li>Île-de-France</li></region><settlement><li>Baltimore</li><li>Leyde</li><li>Madrid</li><li>Paris</li><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Australie"><noRegion><name sortKey="Bellamy, Nicholas" sort="Bellamy, Nicholas" uniqKey="Bellamy N" first="Nicholas" last="Bellamy">Nicholas Bellamy</name></noRegion></country><country name="États-Unis"><region name="Maryland"><name sortKey="Hochberg, Marc" sort="Hochberg, Marc" uniqKey="Hochberg M" first="Marc" last="Hochberg">Marc Hochberg</name></region></country><country name="France"><region name="Île-de-France"><name sortKey="Tubach, Florence" sort="Tubach, Florence" uniqKey="Tubach F" first="Florence" last="Tubach">Florence Tubach</name></region><name sortKey="Dougados, Maxime" sort="Dougados, Maxime" uniqKey="Dougados M" first="Maxime" last="Dougados">Maxime Dougados</name><name sortKey="Logeart, Isabelle" sort="Logeart, Isabelle" uniqKey="Logeart I" first="Isabelle" last="Logeart">Isabelle Logeart</name></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Martin Mola, Emilio" sort="Martin Mola, Emilio" uniqKey="Martin Mola E" first="Emilio" last="Martin-Mola">Emilio Martin-Mola</name></region></country><country name="Liban"><noRegion><name sortKey="Awada, Hassane" sort="Awada, Hassane" uniqKey="Awada H" first="Hassane" last="Awada">Hassane Awada</name></noRegion></country><country name="Canada"><region name="Ontario"><name sortKey="Bombardier, Claire" sort="Bombardier, Claire" uniqKey="Bombardier C" first="Claire" last="Bombardier">Claire Bombardier</name></region></country><country name="Maroc"><noRegion><name sortKey="Hajjaj Hassouni, Najia" sort="Hajjaj Hassouni, Najia" uniqKey="Hajjaj Hassouni N" first="Najia" last="Hajjaj-Hassouni">Najia Hajjaj-Hassouni</name></noRegion></country><country name="Italie"><noRegion><name sortKey="Matucci Cerinic, Marco" sort="Matucci Cerinic, Marco" uniqKey="Matucci Cerinic M" first="Marco" last="Matucci-Cerinic">Marco Matucci-Cerinic</name></noRegion></country><country name="Pays-Bas"><noRegion><name sortKey="Van De Laar, Mart" sort="Van De Laar, Mart" uniqKey="Van De Laar M" first="Mart" last="Van De Laar">Mart Van De Laar</name></noRegion><name sortKey="Van Der Heijde, Desiree" sort="Van Der Heijde, Desiree" uniqKey="Van Der Heijde D" first="Désirée" last="Van Der Heijde">Désirée Van Der Heijde</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D24 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002D24 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25581339
|texte= Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25581339" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |